JANSSEN PHARMS FDA Approval NDA 019641

NDA 019641

JANSSEN PHARMS

FDA Drug Application

Application #019641

Documents

Letter2004-06-30
Letter2013-10-01
Letter2014-07-25
Label2003-03-20
Label2004-07-01
Label2013-09-27
Letter2003-03-25
Letter2003-03-25
Label2003-03-20
Label2014-07-24

Application Sponsors

NDA 019641JANSSEN PHARMS

Marketing Status

Discontinued001

Application Products

001SUPPOSITORY;VAGINAL80MG1TERAZOL 3TERCONAZOLE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP1988-05-24STANDARD
LABELING; LabelingSUPPL3AP1989-11-30
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1989-07-25STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1990-08-21STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1992-09-25STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1993-02-09STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1994-10-17STANDARD
LABELING; LabelingSUPPL9AP1997-07-28STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL11AP1998-10-07STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1999-11-01STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL13AP1999-09-29STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1999-10-08STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL15AP1999-10-08STANDARD
LABELING; LabelingSUPPL16AP2003-03-11STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL17AP2001-09-21STANDARD
LABELING; LabelingSUPPL18AP2003-03-11STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL19AP2001-12-10STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL20AP2002-10-04STANDARD
LABELING; LabelingSUPPL22AP2004-06-30STANDARD
LABELING; LabelingSUPPL28AP2013-09-26STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL29AP2013-07-23STANDARD
LABELING; LabelingSUPPL30AP2014-07-23STANDARD

Submissions Property Types

SUPPL4Null0
SUPPL5Null0
SUPPL6Null0
SUPPL7Null0
SUPPL8Null0
SUPPL11Null0
SUPPL12Null0
SUPPL13Null0
SUPPL14Null0
SUPPL15Null0
SUPPL17Null0
SUPPL19Null0
SUPPL20Null0
SUPPL28Null7
SUPPL29Null0
SUPPL30Null15

CDER Filings

JANSSEN PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 19641
            [companyName] => JANSSEN PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"TERAZOL 3","activeIngredients":"TERCONAZOLE","strength":"80MG","dosageForm":"SUPPOSITORY;VAGINAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
            [labels] => [{"actionDate":"07\/23\/2014","submission":"SUPPL-30","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/019579s037,019641s030,019964s032lbl.pdf\"}]","notes":""},{"actionDate":"09\/26\/2013","submission":"SUPPL-28","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/019579s035,019641s028,019964s030lbl.pdf\"}]","notes":""},{"actionDate":"06\/30\/2004","submission":"SUPPL-22","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2004\\\/19579slr026,19641slr022,19964slr021_terazol_lbl.pdf\"}]","notes":""},{"actionDate":"03\/11\/2003","submission":"SUPPL-18","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2003\\\/019641s016lbl.pdf\"}]","notes":""},{"actionDate":"03\/11\/2003","submission":"SUPPL-16","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2003\\\/019641s016lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"TERAZOL 3","submission":"TERCONAZOLE","actionType":"80MG","submissionClassification":"SUPPOSITORY;VAGINAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2014-07-23
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.